Cardiac Reverse Remodeling and Clinical Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor Therapy in Heart Failure With Reduced Ejection Fraction.
BACKGROUND Cardiac reverse remodeling and associated clinical outcomes following angiotensin receptor-neprilysin inhibitor (ARNI) therapy in patients with heart failure (HF) with reduced ejection fraction (EF) remain unclear. We investigated differences in 1-year echocardiographic response after ARNI therapy and predic...